Singapore LIVE (SingLIVE), Asia-Pacific’s key platform for showcasing advances in interventional cardiology, celebrated its 35th anniversary at SingLIVE 2026. The event took place from 22–24 January 2026 at the Raffles City Convention Centre.

• Scale & Participation: The conference brought together more than 1,300 medical professionals from 33 countries, featuring live demonstrations, discussions on innovations, and immersive training sessions.
• Clinical Focus: SingLIVE 2026 continued its role in advancing cardiac care by featuring live case demonstrations of new technologies, including LithiX Hertz Contact Intravascular Lithotripsy (HC IVL) — a device for treating calcified coronary artery disease more safely and effectively.
• Historical Impact: Since its founding in 1989, SingLIVE has introduced multiple cardiovascular Asia firsts and breakthrough techniques — such as the first coronary stent implantation (1991), the region’s first drug-eluting stent procedure (2002), and Asia’s first transcatheter aortic valve implantation (2009), among others.

This summary is based on a press release issued by the National Heart Centre Singapore.